Thinking Creatively About Treatment-Resistant Depression
J. Alexander Bodkin, MD
Director of the Clinical Psychopharmacology Research Program at McLean Hospital in Belmont, MA; assistant professor of psychiatry at Harvard Medical School
Dr. Bodkin has disclosed that he has been a principal investigator in a study of brexpiprazole. Dr. Carlat has reviewed his interview and has found no evidence of bias in this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729532347 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
